论文标题
部分可观测时空混沌系统的无模型预测
Autism spectrum disorder classification based on interpersonal neural synchrony: Can classification be improved by dyadic neural biomarkers using unsupervised graph representation learning?
论文作者
论文摘要
自闭症谱系障碍(ASD)分类的机器学习研究有望改善临床诊断。但是,最近在临床成像方面的研究表明,生物标志物跨基准数据集的概括有限。尽管在神经影像学中增加了模型的复杂性和样本量,但ASD的分类性能仍然远离临床应用。这就提出了一个问题,即我们如何克服这些障碍来开发ASD的早期生物标志物。一种方法可能是重新考虑我们如何在机器学习模型中运作该疾病的理论基础。在这里,我们介绍了无监督的图表表示,这些图表明确绘制了ASD核心方面的神经机制,二元社会相互作用的缺陷,如双脑记录所评估,称为Hyperscanning,并评估了其预测性能。所提出的方法与现有方法不同,因为它更适合于在神经水平上捕获社会互动缺陷,并且适用于幼儿和婴儿。功能性近红外光谱数据的首先结果表明,任务无关,可解释的图表的潜在预测能力。首先要利用与互动相关的缺陷来对ASD进行分类,这可能会刺激新方法和方法,以增强现有模型以实现未来发展的ASD生物标志物。
Research in machine learning for autism spectrum disorder (ASD) classification bears the promise to improve clinical diagnoses. However, recent studies in clinical imaging have shown the limited generalization of biomarkers across and beyond benchmark datasets. Despite increasing model complexity and sample size in neuroimaging, the classification performance of ASD remains far away from clinical application. This raises the question of how we can overcome these barriers to develop early biomarkers for ASD. One approach might be to rethink how we operationalize the theoretical basis of this disease in machine learning models. Here we introduced unsupervised graph representations that explicitly map the neural mechanisms of a core aspect of ASD, deficits in dyadic social interaction, as assessed by dual brain recordings, termed hyperscanning, and evaluated their predictive performance. The proposed method differs from existing approaches in that it is more suitable to capture social interaction deficits on a neural level and is applicable to young children and infants. First results from functional near-infrared spectroscopy data indicate potential predictive capacities of a task-agnostic, interpretable graph representation. This first effort to leverage interaction-related deficits on neural level to classify ASD may stimulate new approaches and methods to enhance existing models to achieve developmental ASD biomarkers in the future.